InvestorsHub Logo
Followers 20
Posts 2942
Boards Moderated 1
Alias Born 04/27/2000

Re: None

Monday, 02/24/2003 10:25:16 AM

Monday, February 24, 2003 10:25:16 AM

Post# of 110
National Sales Manager and Technical Marketing Manager From $2.7B Chemical Company Join the IBCI/Nova Team
Monday February 3, 9:20 am ET


ATLANTA, Feb. 3 /PRNewswire-FirstCall/ -- International Biochemical Industries, Inc. (OTC Bulletin Board: IBCL - News) announced today that its master distributor, Nova BioGenetics, Inc., has hired its new National Sales Manager and Technical Marketing Manager.

Deirdre Baker, IBCI's General Manager, stated, "The new National Sales Manager and the Technical Marketing Manager positions are a very welcome addition to the IBCI/Nova Team. Both positions were filled to support an aggressive sales campaign."

IBCI/Nova's efforts with this current campaign will highlight extensive technical support through our world class R&D facilities, vertical market initiatives and global product opportunities to capitalize on both existing and prospective customer opportunities. The new sales directive will optimize sales by leading a nationwide network of sales representatives and key accounts. In a later release, the entire network of sales representatives will be named and introduced.

The company welcomes both Jim Joyce and Jodi Martin to these positions and to the IBCI/Nova Team.

About: International BioChemical Industries

International BioChemical Industries, Inc. is a Norcross, Georgia-based emerging growth company focused in biotechnology and antimicrobial products. Its core business is committed to the discovery, development, marketing and sale of surface-modifying antimicrobial and biostatic products. The company's antimicrobial technology is an alternative to conventional sanitizers, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria on contact and can remain active for extended time periods. To date IBCI has received four US patents, four international patents and eight EPA registrations, including the first U.S. germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The company has developed several alliances in different industries, such as healthcare, textiles and storm water.

Further information on IBCI and its line of products can be found by visiting the firm's web site at http://www.bioshield.com , or by calling 1-770-925-3653, Deirdre Baker.

Safe Harbor/Forward-looking Statements:

Statements in this news release that are not historical are forward- looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of IBCI; the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. IBCI does not undertake to revise or update any forward- looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of IBCI.






The best weapon against "fear" is "facts"!!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.